Exagen
XGN
28 hedge funds and large institutions have $20M invested in Exagen in 2023 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 9 increasing their positions, 6 reducing their positions, and 2 closing their positions.
50% more repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 6
20% more capital invested
Capital invested by funds: $16.6M → $20M (+$3.36M)
0.3% more ownership
Funds ownership: 40.6% → 40.9% (+0.3%)
0% more funds holding
Funds holding: 28 → 28 (0)
0% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RI
RTW Investments
New York
|
+$288K |
| 2 |
SAM
Silvercrest Asset Management
New York
|
+$127K |
| 3 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
+$34.9K |
| 4 |
PCM
Perkins Capital Management
Wayzata,
Minnesota
|
+$11.4K |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$8.47K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CAC
Cowen and Company
New York
|
-$288K |
| 2 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
-$30.5K |
| 3 |
Bank of America
Charlotte,
North Carolina
|
-$10.5K |
| 4 |
Millennium Management
New York
|
-$8.96K |
| 5 |
FBT
First Bank & Trust
Brookings,
South Dakota
|
-$6.88K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
JP Morgan Chase
New York
| $6.56K | – | – | – |
|
27
Osaic Holdings
Scottsdale,
Arizona
| $1.89K | – | – | – |
|
|
TRCT
28
Tower Research Capital (TRC)
New York
| $188 | +$185 | +65 | New |
|
|
NA
29
NewEdge Advisors
New Orleans,
Louisiana
| – | -$1.27K | -521 | Closed |
|
XGN Hedge Fund Activity: Q2 2023 in Review
28 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Exagen (XGN) for Q2 2023, worth a combined $20M — up 20% from $16.6M a quarter earlier.
Fund positioning in XGN was balanced in Q2 2023: 2 funds opened new positions, 2 closed out, 9 added to existing stakes and 6 trimmed.
The largest buyer was RTW Investments, adding an estimated $288K. The largest seller was Cowen and Company, cutting an estimated $288K.
- 28 institutional investors held Exagen (XGN) as of Q2 2023, unchanged from Q1 2023.
- Funds reported $20M of Exagen stock for Q2 2023, up 20% quarter-over-quarter.
- 2 funds opened new Exagen positions in Q2 2023 and 2 closed out, a net change of 0 holders.
- The largest Exagen buyer in Q2 2023 was RTW Investments, an estimated $288K added.
- The largest Exagen seller in Q2 2023 was Cowen and Company, an estimated $288K sold.
Based on aggregated 13F filings for Q2 2023.